GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Progyny Inc (NAS:PGNY) » Definitions » Price-to-Free-Cash-Flow

Progyny (Progyny) Price-to-Free-Cash-Flow : 17.59 (As of Apr. 30, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Progyny Price-to-Free-Cash-Flow?

As of today (2024-04-30), Progyny's share price is $32.35. Progyny's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.84. Hence, Progyny's Price-to-Free-Cash-Flow Ratio for today is 17.59.

The historical rank and industry rank for Progyny's Price-to-Free-Cash-Flow or its related term are showing as below:

PGNY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 15.24   Med: 140.34   Max: 781.79
Current: 17.63

During the past 7 years, Progyny's highest Price-to-Free-Cash-Flow Ratio was 781.79. The lowest was 15.24. And the median was 140.34.

PGNY's Price-to-Free-Cash-Flow is ranked better than
50.56% of 356 companies
in the Healthcare Providers & Services industry
Industry Median: 18.04 vs PGNY: 17.63

Progyny's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.37. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.84.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Progyny was 138.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 73.00% per year.

During the past 7 years, Progyny's highest 3-Year average Free Cash Flow per Share Growth Rate was 124.60% per year. The lowest was 73.00% per year. And the median was 98.80% per year.


Progyny Price-to-Free-Cash-Flow Historical Data

The historical data trend for Progyny's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progyny Price-to-Free-Cash-Flow Chart

Progyny Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - 119.41 211.55 40.35 20.22

Progyny Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.35 29.49 23.86 17.18 20.22

Competitive Comparison of Progyny's Price-to-Free-Cash-Flow

For the Health Information Services subindustry, Progyny's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Progyny's Price-to-Free-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Progyny's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Progyny's Price-to-Free-Cash-Flow falls into.



Progyny Price-to-Free-Cash-Flow Calculation

Progyny's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=32.35/1.839
=17.59

Progyny's Share Price of today is $32.35.
Progyny's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Progyny  (NAS:PGNY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Progyny Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Progyny's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Progyny (Progyny) Business Description

Traded in Other Exchanges
N/A
Address
1359 Broadway, New York, NY, USA, 10018
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
Executives
David J Schlanger director, officer: Executive Chairman C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK NY 10018
Michael E Sturmer officer: President 48 LEDYARD RD, WEST HARTFORD CT 06117
Mark S. Livingston officer: Chief Financial Officer C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK NY 10018
Kevin K Gordon director 155 S LIMERICK RD, LIMERICK PA 19468
Tpg Gp A, Llc 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Peter Anevski officer: Chief Executive Officer C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK NY 10018
Cheryl Scott director 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Norman Payson director 800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Allison Swartz officer: EVP, GC C/O PROGYNY, INC., 1359 BROADWAY, NEW YORK NY 10018
Lloyd H Dean director 185 BERRY STREET, SUITE 300, SAN FRANCISCO CA 94107
Monice Barbero officer: EVP, GC and Secretary C/O PROGYNY, INC., 1359 BROADWAY, NEW YORK NY 10018
Jon Winkelried 10 percent owner C/O GOLDMAN, SACHS & CO., 85 BROAD STREET, NEW YORK NY 10004
Beth C Seidenberg director
Jennifer Bealer officer: EVP, General Counsel C/O PROGYNY, INC., 245 5TH AVENUE, NEW YORK NY 10016
Malissia Clinton director 333 THREE D SYSTEMS CIRCLE, ROCK HILL SC 29730